Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
about
Biomarker correlation network in colorectal carcinoma by tumor anatomic location.Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.The colorectal cancer immune microenvironment and approach to immunotherapies.Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaThe predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.Deep learning based tissue analysis predicts outcome in colorectal cancer.Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.T-Cell Transfer Therapy Targeting Mutant KRAS.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality.Treatment of Elderly Patients with Colorectal Cancer.Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer
P2860
Q33808553-7D4DFF8E-5B72-4FDE-A0A5-974CC25ED31DQ36345775-9CD4D411-7193-4A17-B12F-816FD926732AQ36405971-0EAE9C44-0BFE-430B-B8F4-B2C9A17C242FQ37736897-A3108426-C98E-4823-AE8C-BA8AA7AD33ACQ38638847-3353F023-D595-42F6-882A-D0E0A38A90ACQ38761014-240B3739-BF13-4248-9A6E-135FFE577A48Q39294187-1723CB34-22DC-4B37-A8AB-15EF0365BA11Q40060444-47CF51B8-6020-455A-ADA9-A44CD4CBFB14Q42396426-CFA4B71A-40B3-4D8C-ABD4-498B60FDFFE2Q46540302-1D6BA1C5-318C-4689-A546-DB218FD0B63DQ47192478-0874ADAA-6919-4875-974E-A434412C6A37Q48249876-005F0CD7-EBB0-41DC-AAE1-B0404D995E64Q48307824-EA3C543B-D2CE-40EF-9995-6D768D9E3A3AQ50043586-E728EE26-2461-406B-BEFB-577742991729Q50077322-FE8048B1-76CF-4EB7-85CB-E479F70E5A4BQ50332434-366A00E7-38DC-4600-975A-EC2E6165613EQ51045025-91248CE7-E982-47F3-9067-A305B080C216Q51135353-CF32D7FF-6631-461D-8E38-19D1AAB2B0C0Q52320729-E89ECE94-A8A0-43D9-A282-F0C851CCA59FQ53601791-45CA76CB-7BE8-4C0F-9259-1BFE5FEAE5EDQ55250651-DE1960C9-35D2-4E07-B142-1EDACDB6BB25Q55424174-E0AE391E-ACD1-487F-897E-7C41D74E35FEQ58704497-78FF5B0B-D3FF-4329-8408-E00E7668111A
P2860
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumor-Infiltrating Lymphocytes ...... rvival From Colorectal Cancer.
@en
type
label
Tumor-Infiltrating Lymphocytes ...... rvival From Colorectal Cancer.
@en
prefLabel
Tumor-Infiltrating Lymphocytes ...... rvival From Colorectal Cancer.
@en
P2093
P2860
P356
P1476
Tumor-Infiltrating Lymphocytes ...... rvival From Colorectal Cancer.
@en
P2093
Hedy S Rennert
Joel K Greenson
Laura S Rozek
Lynn P Tomsho
Stephanie L Schmit
Stephen B Gruber
P2860
P356
10.1093/JNCI/DJW027
P407
P50
P577
2016-05-12T00:00:00Z